# Acurx Pharmaceuticals, Inc.: Form DEF 14A, filed Sep 1, 2026

- Company: [Acurx Pharmaceuticals, Inc.](/companies/acxp.md) (CIK 1736243)
- Form: DEF 14A
- Filed: 2026-09-01
- Accepted by EDGAR: Sep 1, 2026, 16:15 ET
- Period: 2026-10-16
- Accession: 0001104659-26-104316
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1736243/000110465926104316/tm262428-1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736243/000110465926104316/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736243/000110465926104316/tm262428-1_def14a.htm

Filed Sep 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-104316. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
